Fera Pharmaceuticals Announces FDA Approval of Avaclyr Approvals, FDA/Regulatory, Herpetic keratitis, New Drug Applications, Ointments, Orphan Drug Designation, Viral Infections The U.S. Food and Drug Administration approved Fera’s New Drug Application for Avaclyr (acyclovir ophthalmic ointment) 3% for the treatment of herpetic keratitis. Read more April 1, 2019/by Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Business Wire2019-04-01 13:14:182019-04-02 13:18:56Fera Pharmaceuticals Announces FDA Approval of Avaclyr
